Paris Paris Paris

THANK YOU FOR ATTENDING

Dear Friends and Colleagues, thank you for having joined us at the 2nd World Congress on Controversies in Multiple Myeloma (COMy), Paris, France on April 28-30, 2016.

COMy Paris - Highlights

CME via the EBAH-CME

CME ACCREDITATION

We are pleased to announce the 2nd World World Congress on Controversies in Multiple Myeloma (COMy) has been awarded
 
 16 (sixteen) EBHA-CME Credit Points.
Read more >>

Important Information

https://upload.wikimedia.org/wikipedia/en/thumb/9/9f/Twitter_bird_logo_2012.svg/945px-Twitter_bird_logo_2012.svg.png  Follow us on Twitter for CONTINUED UPDATES @COMyCongress and via #comy

COMy Paris
Participant Feedback Form
We welcome you while with us on-site or just after the COMy Congress in Paris to take a few minutes to leave your feedback via our online survey

Multiple Myeloma - Features


New Developments in Multiple Myeloma

Frontline Therapy for Multiple Myeloma

Assessment and Treatment for Smoldering Myeloma

Monoclonal Antibodies and Checkpoint Inhibitors

Congress chairs


    
Prof. Mohamad Mohty
France
Congress Co-chair 		 Prof. Thierry Facon
France
Local chair 		Prof. Arnon Nagler
Israel
Congress Co-chair

Paris in the springtime

Enjoy Paris, the French capital before the heat and the hordes of summer arrive...

COMy 2016 - Program objectives

Multiple Myeloma in 2016: The search for a cure?
Multiple Myeloma biology and diagnosis
Bone disease
Treatment of younger multiple myeloma patients
Management of side effects
Maintenance and consolidation after transplantation
New Multiple Myeloma drug developments
Multiple Myeloma clinical case discussions
Waldenstrom disease
Treatment of elderly myeloma patients
Treatment of relapsed myeloma
Biology of the disease
Imaging and disease assessment
Special lectures
Frontline therapy
Innovative approaches and case discussions
Smoldering myeloma
Treatment of relapse
Immunotherapy
Specific approaches
Closing Session: the future